These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

555 related items for PubMed ID: 30418592

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Central Nervous System Lymphoma.
    Chukwueke UN, Nayak L.
    Hematol Oncol Clin North Am; 2019 Aug; 33(4):597-611. PubMed ID: 31229157
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Evolution of the treatment of primary central nervous system lymphoma in a Regional Cancer Center of South India: Impact of high-dose methotrexate on treatment outcome.
    Rudresha AH, Chaudhuri T, Lakshmaiah KC, Babu G, Lokesh KN, Rajeev LK.
    J Cancer Res Ther; 2020 Aug; 16(1):13-17. PubMed ID: 32362603
    [Abstract] [Full Text] [Related]

  • 6. Treatment of Primary CNS Lymphoma: Maximizing Clinical Benefit, Minimizing Neurotoxicity.
    Song KW, Batchelor T.
    Curr Oncol Rep; 2021 Sep 15; 23(11):132. PubMed ID: 34524547
    [Abstract] [Full Text] [Related]

  • 7. Treatment of newly diagnosed primary central nervous system lymphoma: current and emerging therapies.
    Sethi TK, Reddy NM.
    Leuk Lymphoma; 2019 Jan 15; 60(1):6-18. PubMed ID: 29741421
    [Abstract] [Full Text] [Related]

  • 8. Primary CNS Lymphoma.
    Grommes C, DeAngelis LM.
    J Clin Oncol; 2017 Jul 20; 35(21):2410-2418. PubMed ID: 28640701
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Combined treatment of rituximab, idarubicin, dexamethasone, cytarabine, methotrexate with radiotherapy for primary central nervous system lymphoma.
    Zhao D, Qian L, Shen J, Liu X, Mei K, Cen J, Wang Y, Li C, Ma Y.
    J Cell Mol Med; 2014 Jun 20; 18(6):1081-6. PubMed ID: 24628986
    [Abstract] [Full Text] [Related]

  • 11. A Rare Case of Primary Central Nervous System Lymphoma in an Adolescent Female Treated with High-Dose Methotrexate and Rituximab-Based Chemoimmunotherapy and Consolidation Whole Brain Radiotherapy.
    Biswas A, Adhikari N, Bakhshi S, Gopinathan VR, Sharma MC.
    Pediatr Neurosurg; 2019 Jun 20; 54(1):57-65. PubMed ID: 30669145
    [Abstract] [Full Text] [Related]

  • 12. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL, Marton E, Plander M, Gyánó G, Czumbil L, Tóth C.
    Orv Hetil; 2009 Oct 18; 150(42):1937-44. PubMed ID: 19812012
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Salvage chemoimmunotherapy with rituximab, ifosfamide and etoposide (R-IE regimen) in patients with primary CNS lymphoma relapsed or refractory to high-dose methotrexate-based chemotherapy.
    Mappa S, Marturano E, Licata G, Frezzato M, Frungillo N, Ilariucci F, Stelitano C, Ferrari A, Sorarù M, Vianello F, Baldini L, Proserpio I, Foppoli M, Assanelli A, Reni M, Caligaris-Cappio F, Ferreri AJ.
    Hematol Oncol; 2013 Sep 18; 31(3):143-50. PubMed ID: 23161567
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.